Lumenis
 | |
|
Company employee before an equipment supplied for intense pulsed light. | |
Formerly called | E.S.C. – Energy Systems Corporation Ltd. |
|---|---|
| Public company | |
| Traded as | |
| Industry | Medical devices |
| Founded | December 21, 1991 in Yokneam, Israel |
| Headquarters | Yokneam, Israel |
Area served | Worldwide |
Key people |
Tzipi Ozer-Armon (CEO) Ophir Yakovian (CFO) |
| Products |
Lumenis Pulse, AcuPulse, UltraPulse LightSheer, M22, Selecta Array Laser Link, Vision One |
| Revenue | $265,3 million (2013)[1] |
| $25,6 million (2013)[1] | |
| $17,3 million (2013)[1] | |
| Total assets | $206,4 million (2013)[1] |
Number of employees | 1000+ |
| Website |
lumenis |
Lumenis (in Latin: Light of Life) is the largest worldwide manufacturer of medical laser equipment,[2] with the applications ranging from the field of ophthalmology to aesthetic and surgical devices. The company is headquartered in the Yokneam Industrial Park in Yokneam, Israel. The subsidiaries are located in the United States in San Jose, California and Salt Lake City in Utah. It also has offices in the United Kingdom, France, Italy, Germany, Holland, Japan and Hong Kong.[3] The company has about 250 medical patents.[4]
History
The company was founded in 1991 under the name E.S.C. – Energy Systems Corporation Ltd. However, in 2001, after the acquisition of an Israeli company ESC Medical Systems, and American Coherent Medical Group for $203 million. Due to problems with the financial statements in 2004, the company shares were removed from quotation on the stock exchange NASDAQ.[5] In 2006, in exchange for an investment of $120 million, 75% of Lumenis stakes were sold to two private Israeli companies, LM Partners LP and Ofer Hi-Tech Group.
In February 2014, under new management, Lumenis went public again by listing on the NASDAQ Global Select Market under the symbol "LMNS".[6]
Products
- Surgical lasers - treatment of diseases in the field of urology, gastroenterology, ENT, gynecology, and orthopedics. Lumenis is the pioneer in innovations such as Holmium and CO2 medical lasers,
- Ophthalmic devices - operations on the retina, glaucoma, cataract and periocular. Lumenis introduced the first ophthalmic Argon photocoagulator, and it stands behind Selective Laser Trabeculoplasty (SLT), for managing open-angle glaucoma,
- Devices for aesthetic medicine - procedures with numerous inventions, such as Intense Pulsed Light and CO2 fractional skin resurfacing, technologies such as Lightsheer for hair removal and ResurFX for non-ablative skin resurfacing.
Equipment
- Lumenis Pulse 120H
- VersaPulsePowerSuite
- UltraPulse
- AcuPulse DUO
- AcuPulse
- M22
- LightSheer Desire
- LightSheer Duet
- LightSheer Infinity
- QX Max
- Vision One
- Selecta Duet
- Selecta Trio
- Array Laser Link
- Novus Spectra
- Aura PT
Key people
- Tzipi Ozer-Armon - Chief Executive Officer (CEO)
- Ophir Yakovian - Chief Financial Officer (CFO)
- Roy Ramati - Vice President & General Manager, Aesthetic SBU
- Ezi Hayon - Vice President & General Manager, Surgical SBU
- Hadas Padan - Vice President & General Manager, Vision SBU
- Qiying Zhai - SVP and Regional President, Lumenis China and APAC
- Kevin McGann - Vice President & Regional President, Americas
- Masahiro Takakura - Vice President & Regional President, Japan
- Yuval Shani - Vice President, Global Operations
- Ayelet Peled - Vice President, Global Human Resources
- Kfir Azoulay - Vice President, Corporate Marketing
- Amir Lichter - Vice President, Global R&D
- Eran Cohen - Vice President, Global Service
- Rick Gaykowski - Vice President, Regulatory Affairs and Quality
See also
References
- ↑ 1.0 1.1 1.2 1.3 "Lumenis Ltd. Information". NASDAQ. Retrieved 16 November 2014.
- ↑ "Lumenis e Alma resolver processo judicial de patentes pendentes nos Chicago tribunal distrital" (in Portuguese). News Medical. 22 November 2010. Retrieved 16 November 2014.
- ↑ "Global Outsourcing On the Rise". CRN. 13 May 2005. Retrieved 17 November 2014.
- ↑ W. Plunkett, Jack (2006). Plunkett's Health Care Industry Almanac 2007. Plunkett Research, Ltd. ISBN 978-1593920791.
- ↑ Alon, Ido; Yom Tov, Shirley (6 February 2004). "Lumenis delists from Nasdaq, share slumps 37%". Haaretz. Retrieved 16 November 2014.
- ↑ "Lumenis to Ring the NASDAQ Stock Market Closing Bell on June 19, 2014". Reuters. 19 June 2014. Retrieved 16 November 2014.
External links
| ||||||||||||||||||||||||||||||||||
